AGM 2021

May 14, 2021

Hello, everyone. Welcome to the Integra Life Sciences Holdings Corporation Annual Meeting of Stockholders. I will now pass the call to Peter Arduini. Thank you. Good morning. It's now nine a. M. Eastern Daylight Time on Friday, 05/14/2021. This is the meeting officially called to order. And I'm Peter Arduini, President and Chief Executive Officer of the company, and I want to welcome you to the twenty twenty one Annual Meeting of Stockholders of Integra Life Sciences Holding Corporation. Eric Schwartz, Secretary of the company, will act as Secretary of the meeting. In light of the COVID-nineteen pandemic, as we did last year, this annual meeting will be conducted in a virtual format. We're pleased to be able to hold a meeting that interested shareholders can attend virtually, enabling everyone to be safe. I do want to take a moment at the outset to thank the company's employees around the world for their resiliency and dedication during the COVID-nineteen pandemic. And we're also grateful for the health care professionals and other essential workers that have been caring for all of us during these challenging times. And with that, I'll turn the call over to Eric for some brief introductory comments. Eric? Thank you, Pete. The rules of conduct and procedures for this meeting are posted on the web portal. As stated in those rules, for the stockholders attending via the web portal, questions regarding matters to be voted on at the meeting can now be submitted through the web portal. Also, as an important reminder, if you voted your shares prior to the start of the annual meeting, whether by proxy card, Internet, or phone, your vote has been received by the company's inspector of elections, and there is no need to vote those shares again during the annual meeting unless you wish to revoke or change your vote. Back to you, Mr. Chairman. Thank you, Eric. As an initial matter, I'd like to introduce you to Integra's directors, all of whom are in virtual attendance for today's meeting. In addition to me, the company's directors are as follows: Stuart Essek, Chairman of the Board Barbara Hill, our Presiding Director Keith Bradley Rhonda Germany Ballantyne Chandra Clay Don Morell Ray Murphy, and Chris Shade. Company's Chief Operating Officer, Glenn Coleman, and Chief Financial Officer, Carrie Anderson, are also in attendance, as is Lisha Shin, Deputy General Counsel, Corporate and Business Development and Assistant Secretary. In addition, our auditors from PwC are present and are represented by Chad Bond. And with that, we'll begin the formal business of the meeting. This meeting has been called as in pursuant of due notice, Proxies were solicited on behalf of the Board of Directors of the company for this meeting. The company has appointed Broadridge Financial Services to act as Inspector of Elections. Lewis Larson from Broadridge is with us today and will act as the Inspector of Elections for the meeting and any of the four matters on today's agenda. Secretary, are there any such questions? Mr. Chairman, there are no such questions. So please proceed to the matters to be voted on at the meeting. Thank you. The first order of business is the election of nine directors to hold office subject to the provisions of the bylaws until the next annual meeting of stockholders and until their respective successors shall have been duly elected and qualified. Nominations are now open. Mr. Chairman, I nominate Peter Arduini, Rhonda Germany Ballantyne, Keith Bradley, Chandra Clay, Stuart Essex, Barbara Hill, Donald Morell, Raymond Murphy and Christian Shade, each of whom is currently a Director of the company and a nominee in the company's proxy statement as Directors of the company to hold office subject to the provisions of the bylaws until the next annual meeting of stockholders and until their respective successors shall have been duly elected and qualified. Mr. Chairman, I second the nomination.